Communiqués Treace Medical Concepts, Inc.

Actions

TMCI

US89455T1097

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq 22:00:00 17/09/2026			Varia. 5j.	Varia. 1 janv.
4,530 ^USD	-0,66%		+4,14%	+84,90%

17/09	Treace Medical Concepts annonce les résultats de trois études cliniques, dont l'étude phare Align3d sur cinq ans, démontrant des résultats positifs durables pour la procédure Lapiplasty	CI
15/09	Treace Medical Concepts, Inc. met en avant ses innovations produits et ses données cliniques au sein de son portefeuille élargi pour le pied et la cheville lors du congrès annuel de l'AOFAS	CI

Communiqués

17/09	Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure	GL
15/09	Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting	GL
07/08	Treace Medical Concepts: Q2 Earnings Snapshot	AQ
07/08	Treace Medical Concepts Reports Second Quarter 2026 Financial Results	GL
24/07	Treace to Report Second Quarter 2026 Financial Results on August 7, 2026	GL
18/06	Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System	GL
11/06	Treace to Present at the Sidoti Small Cap Conference	GL
08/05	Treace Medical Concepts: Q1 Earnings Snapshot	AQ
08/05	Treace Medical Concepts Reports First Quarter 2026 Financial Results	GL
27/04	Treace to Report First Quarter 2026 Financial Results on May 8, 2026	AQ
24/04	Treace to Report First Quarter 2026 Financial Results on May 8, 2026	GL
07/04	Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System	GL
02/03	Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results	AQ
27/02	Treace Medical Concepts: Q4 Earnings Snapshot	AQ
27/02	Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results	GL
24/02	Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference	GL
12/02	Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026	GL
13/01	Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue	GL
08/01	Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology	GL
30/12	Treace to Present at 44th Annual J.P. Morgan Healthcare Conference	GL
18/12	Treace Medical Secures Up to $175 Million in Debt Financing	GL
18/12	Treace Medical Secures Up to $175 Million in Debt Financing	AQ
07/11	Treace Announces Participation in Two Upcoming Investor Conferences	GL
06/11	Treace Medical Concepts: Q3 Earnings Snapshot	AQ
06/11	Treace Medical Concepts Reports Third Quarter 2025 Financial Results	GL